Express Scripts Sues FTC to Withdraw Controversial PBM Report
Legal Dispute: Express Scripts vs. FTC
In a striking legal maneuver, Express Scripts, part of The Cigna Group, has initiated a lawsuit in federal court in Missouri. This action seeks the withdrawal of the FTC's report on Pharmacy Benefit Managers (PBM), which has come under fire for perceived inaccuracies and biases.
Concerns Over FTC Report
The FTC report alleges various irregularities within the PBM sector, painting a picture that Express Scripts claims misrepresents its operations and impacts public perception.
Potential Industry Impacts
If successful in their lawsuit, Express Scripts could not only clear its name but also influence the regulatory landscape for PBMs moving forward. This case highlights the tensions between regulatory bodies and healthcare providers, with potential ramifications for market dynamics.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.